Overview

Infant TB Infection Prevention Study

Status:
Completed

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

Randomized controlled trial (RCT) of isoniazid (INH) vs. no INH to prevent Mycobacterium tuberculosis infection in HIV-exposed uninfected (HEU) infants.

Phase:

Phase 2

Details

Lead Sponsor:

University of Washington

Collaborator:

Thrasher Research Fund

Treatments:

Isoniazid